Chembio Diagnostics (CEMI) News Today → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free CEMI Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineANY LAB TEST NOW Forms Strategic Partnership with Chembiofinance.yahoo.com - April 17 at 7:14 PMQuest Diagnostics Inc DGXmorningstar.com - November 2 at 8:56 AMQualigen Therapeutics Sells FastPack Diagnostics Business to Chembiomarketwatch.com - July 24 at 12:08 PMBiosynex Completes Acquisition of Chembio Diagnostics, Inc.finance.yahoo.com - April 27 at 8:13 PMAnalysts Have Conflicting Sentiments on These Healthcare Companies: Laboratory (LH), Arbutus Biopharma (ABUS) and Chembio Diagnostics (CEMI)markets.businessinsider.com - April 27 at 10:11 AMShareholder Alert: Ademi LLP investigates whether Chembio Diagnostics, Inc. has obtained a Fair Price in its transaction with Biosynexbenzinga.com - April 20 at 4:08 PMChembio Stockholders Urged to Tender Shares Before 6:00 P.M., New York City Time, on April 26, 2023finance.yahoo.com - April 19 at 8:44 AMChembio Diagnostics And 2 Other Stocks Under $1 Insiders Are Aggressively Buyingmsn.com - April 14 at 12:27 PMChembio Stockholders Reminded to Tender Shares Before 6:00 P.M., New York City Time, on April 12, 2023finance.yahoo.com - April 10 at 10:43 AMChembio’s CEO Letter to Stockholdersfinance.yahoo.com - April 3 at 6:43 PMChembio Stockholders Reminded to Tender Shares Before 6:00 PM New York City Time, on March 28, 2023finance.yahoo.com - March 21 at 8:31 AMBiosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.finance.yahoo.com - March 15 at 9:40 AMChembio Announces Letter to Stockholders Regarding Tender Offerfinance.yahoo.com - March 15 at 9:40 AMChembio Announces the Receipt of CLIA Waiver for its DPP HIV-Syphilis Systemfinance.yahoo.com - February 24 at 9:34 AMMoore Kuehn Encourages ALBO, LPTX, ALR, and CEMI Investors to Contact Law Firmbenzinga.com - February 8 at 3:43 PMSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Chembio Diagnostics, Inc. Buyoutwsj.com - February 2 at 7:11 PMFrench Rapid Testing Company Scoops Up Chembio Diagnostics For $17Mfinance.yahoo.com - February 1 at 5:25 PMBiosynex and Chembio Diagnostics Announce Definitive Acquisition Agreementfinance.yahoo.com - January 31 at 9:16 PMmarketbeat.com - January 31 at 4:59 PMCEMI Chembio Diagnostics, Inc.seekingalpha.com - January 21 at 8:44 PMChembio Diagnosticsforbes.com - January 7 at 6:01 PMChembio Announces FDA CLIA Waiver Submission for DPP HIV-Syphilis Systemfinance.yahoo.com - November 28 at 6:06 PMChembio Diagnostics, Inc. (CEMI) Q3 2022 Earnings Call Transcriptseekingalpha.com - November 6 at 1:28 PMChembio Diagnostics Reports Third Quarter 2022 Financial Resultsfinance.yahoo.com - November 3 at 5:24 PMChembio Diagnostics to Report Third Quarter 2022 Financial Results on November 3, 2022finance.yahoo.com - October 20 at 8:54 PMChembio Diagnostics Awarded $3.2 Million Contract from the CDC for Development and Clinical Validation of Dual-Path Platform Syphilis Screen & Confirm Assayfinance.yahoo.com - September 6 at 8:36 AMIs Monkeypox Outbreak Cooling? Health Officials Says Virus Transmission Has Slowedfinance.yahoo.com - September 3 at 1:30 AMRapid Test For Monkeypox? NY-Based Chembio Diagnostics Thinks They Can Pull It Offfinance.yahoo.com - August 16 at 3:46 PMChembio Diagnostics Evaluates Monkeypox Rapid Point-of-Care Test Developmentfinance.yahoo.com - August 16 at 10:45 AMChembio Diagnostics Reports Second Quarter 2022 Financial Resultsfinance.yahoo.com - August 4 at 7:04 PMChembio Diagnostics to Report Second Quarter 2022 Financial Results on August 4, 2022finance.yahoo.com - July 21 at 5:48 PMChembio Expands Distributionbaystreet.ca - June 15 at 4:25 PMChembio Diagnostics Announces Expansion of Direct-to-Consumer Commercial Channelfinance.yahoo.com - June 15 at 9:39 AMChembio's inks contract for HIV test to be made by Reszon Diagnostics at Malaysia facilityseekingalpha.com - May 17 at 12:04 PMChembio Diagnostics Announces Agreement for Reszon Diagnostics International to Manufacture Chembio’s HIV 1/2 STAT-PAK Assay at Chembio Diagnostics Malaysia Facilityfinance.yahoo.com - May 17 at 12:04 PMChembio Diagnostics, Inc. (CEMI) CEO Rick Eberly on Q1 2022 Results - Earnings Call Transcriptseekingalpha.com - May 8 at 9:36 AMChembio Diagnostics Reports First Quarter 2022 Financial Resultsfinance.yahoo.com - May 5 at 5:38 PMChembio Diagnostics Q1 2022 Earnings Previewseekingalpha.com - May 4 at 9:25 PMChembio Diagnostics to Report First Quarter 2022 Financial Results on May 5, 2022finance.yahoo.com - April 21 at 7:44 PMWhy Chembio Diagnostics Shares Are Fallingbenzinga.com - March 4 at 7:19 PMChembio Diagnostics Reports Fourth Quarter and Full Year 2021 Financial Resultsfinance.yahoo.com - March 3 at 6:14 PMChembio Diagnostics Q4 2021 Earnings Previewseekingalpha.com - March 3 at 1:47 AMChembio Diagnostics to Report Fourth Quarter and Full Year 2021 Financial Results on March 3, 2022finance.yahoo.com - February 17 at 7:31 PMChembio Diagnostics, Inc. Common Stock (CEMI)nasdaq.com - January 21 at 11:03 PMChembio Diagnostics appoints CFOseekingalpha.com - January 5 at 7:59 PMChembio Diagnostics Announces Appointment of Larry Steenvoorden as Chief Financial Officerfinance.yahoo.com - January 5 at 7:59 PMChembio Diagnostics Inc. Shares Close the Day 30.1% Lower - Daily Wrapnasdaq.com - December 30 at 8:23 AMChembio Diagnostics Slides After FDA Declines to Review EUAfinance.yahoo.com - December 29 at 5:48 PMPre-market Movers: PIXY, NEW, CEMI, SYTA, AUVI…markets.businessinsider.com - December 29 at 7:47 AMChembio Diagnostics Receives SAHPRA Approval for DPP SARS-CoV-2 Antigen Testfinance.yahoo.com - November 29 at 11:00 AM Get Chembio Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for CEMI and its competitors with MarketBeat's FREE daily newsletter. Email Address This Apple-like Innovator is Revolutionizing Healthcare (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world. Click here to learn more about the booming eHealth industry CEMI Media Mentions By Week CEMI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CEMI News Sentiment▼0.000.44▲Average Medical News Sentiment CEMI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CEMI Articles This Week▼10▲CEMI Articles Average Week Get Chembio Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for CEMI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NeuroBo Pharmaceuticals News Today Avalo Therapeutics News Today Aytu BioPharma News Today Pieris Pharmaceuticals News Today Talphera News Today Minerva Neurosciences News Today Orgenesis News Today Galecto News Today Cocrystal Pharma News Today VBI Vaccines News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CEMI) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority Goldtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chembio Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
